Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure.
Candesartan cilexetil is an angiotensin receptor antagonist widely used in the treatment of high blood pressure. This prodrug is metabolised into candesartan, which blocks the receptors AT1 for angiotensin II decreasing the blood pressure levels. During the development of a solid phase extraction procedure for the chromatographic determination of eight antihypertensive compounds, lack of linearity and reproducibility was observed only for candesartan cilexetil. Due to this fact, a stability study for this prodrug was performed. It showed that the lack of linearity and reproducibility was based on hydrolysis and transesterification processes which occurred during the drying step after elution with methanol into glass tubes. These phenomena could be reproduced artificially under basic conditions, which demonstrated the presence of basic residues in glass tubes. The study of this potential hydrolysis and transesterification reactions is very important to assure that labile drugs containing ester groups remain unaffected.
Ferreirós
Nerea
N
Institute of Forensic Medicine, Forensic Toxicology, University Hospital, Albertstrasse 9, Freiburg, Germany.
Dresen
Sebastian
S
Alonso
Rosa María
RM
Weinmann
Wolfgang
W
D000959:Antihypertensive Agents / Q000737:chemistry* / Q000302:isolation & purification*; D001562:Benzimidazoles / Q000737:chemistry* / Q000302:isolation & purification*; D001713:Biphenyl Compounds / Q000737:chemistry* / Q000302:isolation & purification*; D004951:Esterification; D006868:Hydrolysis; D013058:Mass Spectrometry; D052616:Solid Phase Extraction; D013777:Tetrazoles / Q000737:chemistry* / Q000302:isolation & purification*
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C077793:candesartan cilexetil